- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01440777
Effectiveness and Adherence to an Online Sleep Program
May 6, 2022 updated by: Linda Libertini, The Cleveland Clinic
Effectiveness and Adherence to an Online Sleep Program - A Pilot Study
This research will examine the effectiveness of a 6-week online sleep program (Go!
To Sleep) which provides a set of various psycho-educational materials and behavioral techniques to reduce insomnia symptoms, improve sleep, and improve quality of life.
Study Overview
Study Type
Interventional
Enrollment (Actual)
101
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 to 70 years old.
- Currently living in the continental United States and Canada.
Symptoms of insomnia based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) definition of insomnia disorder:
- Self-reported sleep difficulties (including sleep-onset latency, waking after sleep onset, early waking of more than 30 min duration) 3 or more times a week in the past 3 months.
- Self-reported insomnia problem for more than 3 months.
- Self-reported significant daytime impairment due to sleep difficulties.
- Willingness to log onto the internet on a regular basis for the duration of the study (3-7 months).
- Willingness and able to complete almost daily a sleep log to track sleep pattern for up to 2 months at a time (approximately 2-3 min daily).
- Willingness to be in the Wait-list control group and not have access to the program for 3 months.
Exclusion Criteria:
- Pregnant or planning to be pregnant in the next 6 months.
- Lack of internet access and/or Mac computer at place of residence.
- Currently participating or have participated in group or individual therapy for insomnia in the prior month.
- Patient Health Questionnaire (PHQ9) depression score >14.
- Recent treatment (less than 3 months) or medication for depression or anxiety.
- Change in treatment or medication for depression or anxiety in the past month or planned change in the next 3 months.
- Current treatment (therapy, prescription) for any other psychological or emotional conditions (including but not limited to: mania, manic-depression, psychosis, schizophrenia, adjustment disorder).
- Diagnosed and currently suffering from a sleep disorder (including, but not limited to sleep apnea, restless leg syndrome, sleep walking, narcolepsy) which is untreated or has been treated for less than a month.
- Suffer from physical symptoms or medical conditions that may affect sleep (including but not limited to: pain, arthritis, tinnitus, diabetes, night time cough, shortness of breath, hot flashes, frequent urination, heartburn).
- Steroid an stimulant use (including but not limited to prednisone, methylprednisolone or Solumedrol (for inflammatory disorders), methylphenidate, or Ritalin (for Attention-Deficit Hyperactivity disorder), Provigil (for narcolepsy), Wellbutrin or Zyban (for tobacco cessation), cocaine or methylenedioxymethamphetamine (MDMA) (a.k.a. Ecstasy)).
- Irregular workshift.
- Having young children who may affect sleep pattern.
- Taking over-the-counter or prescribed sleep medication 3 or more times a week.
- Alcoholism.
- Inability to access the internet on a consistent regular basis for the duration of the study (3-7 months).
- Inability to complete daily sleep log to track sleep patterns for up to 2 months at a time.
- Unwillingness to be assigned to the wait-list control group for 3 months prior to gaining access to the program.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Go! to Sleep
Participants access and utilize the 6-week online program that provides a set of various psycho-educational materials and behavioral techniques to treat insomnia.
|
The online program provides various tools for the delivery of the intervention including:
|
|
No Intervention: Control Group
No intervention provided.
These participants will receive the Go! to Sleep program after the research trial has been completed (10 weeks after registration).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia severity
Time Frame: 5 months
|
To assess the effectiveness of the online Go! to Sleep program in improving sleep by measuring insomnia severity using the Insomnia Severity Index (ISI).
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia symptoms
Time Frame: 5 months
|
To determine if the program helps improve insomnia symptoms as measured by the Pittsburgh Insomnia Rating Scale (PIRS)
|
5 months
|
|
Sleep pattern
Time Frame: 5 months
|
To determine if the program helps improve sleep-onset latency (SOL), total sleep time (TST), waking after sleep onset (WASO) (within Go To Sleep! group analysis only)
|
5 months
|
|
Daytime Dysfunction
Time Frame: 5 months
|
To determine if the program improves daytime dysfunction (Pittsburgh Sleep Quality Index subscale)
|
5 months
|
|
Stress
Time Frame: 5 months
|
To assess whether the program reduces stress as measured by the Perceived Stress Scale (PSS10)
|
5 months
|
|
Program adherence
Time Frame: 5 months
|
To assess program adherence and its relation to program effectiveness
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adam Bernstein, M.D., The Cleveland Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
September 23, 2011
First Submitted That Met QC Criteria
September 26, 2011
First Posted (Estimate)
September 27, 2011
Study Record Updates
Last Update Posted (Actual)
May 11, 2022
Last Update Submitted That Met QC Criteria
May 6, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB# 11-860
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteRecruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
NYU Langone HealthNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedInsomniaUnited States
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Completed
Clinical Trials on Go! to Sleep
-
University of South FloridaCompletedObesity | Insomnia | Weight Loss | Sleep Disordered Breathing | PostpartumUnited States
-
Brigham and Women's HospitalThe Cleveland ClinicCompleted
-
Case Comprehensive Cancer CenterCompletedBreast Cancer | SleepUnited States
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); United... and other collaboratorsCompletedObesity | Eating Behavior
-
Vrije Universiteit BrusselNot yet recruitingMental Fatigue | NIRS | Condition | Near Infrared Spectroscopy | Cerebral HeamodynamicsBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Koko Home, Inc.Stanford UniversityRecruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep HygieneUnited States
-
Florida Atlantic UniversityCompletedChronic Disease | Acute DiseaseUnited States
-
The Cleveland ClinicKugona LLCCompletedAutism Spectrum DisordersUnited States
-
Medstar Health Research InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed